These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21648351)

  • 41. Risperidone improves behavioral symptoms in children with autism in a randomized, double-blind, placebo-controlled trial.
    Pandina GJ; Bossie CA; Youssef E; Zhu Y; Dunbar F
    J Autism Dev Disord; 2007 Feb; 37(2):367-73. PubMed ID: 17019624
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Methodological issues in designing a multisite trial of risperidone in children and adolescents with autism.
    Scahill L; McCracken J; McDougle CJ; Aman M; Arnold LE; Tierney E; Cronin P; Davies M; Ghuman J; Gonzalez N; Koenig K; Lindsay R; Martin A; McGough J; Posey DJ; Swiezy N; Volkmar F; Ritz L; Vitiello B
    J Child Adolesc Psychopharmacol; 2001; 11(4):377-88. PubMed ID: 11838820
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risperidone and adaptive behavior in children with autism.
    Williams SK; Scahill L; Vitiello B; Aman MG; Arnold LE; McDougle CJ; McCracken JT; Tierney E; Ritz L; Posey DJ; Swiezy NB; Hollway J; Cronin P; Ghuman J; Wheeler C; Cicchetti D; Sparrow S
    J Am Acad Child Adolesc Psychiatry; 2006 Apr; 45(4):431-9. PubMed ID: 16601648
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risperidone-induced paroxysmal perceptual alteration in a child with autism.
    Bozkurt H; Ayaydın H; Adak İ; Zoroğlu SS
    J Child Adolesc Psychopharmacol; 2012 Dec; 22(6):470-1. PubMed ID: 23234592
    [No Abstract]   [Full Text] [Related]  

  • 45. Abnormal movements with the addition of clindamycin to risperidone in a girl with autism.
    Malone RP; Harvey JA
    J Child Adolesc Psychopharmacol; 2008 Apr; 18(2):221-2. PubMed ID: 18439121
    [No Abstract]   [Full Text] [Related]  

  • 46. Parent satisfaction in a multi-site acute trial of risperidone in children with autism: a social validity study.
    Tierney E; Aman M; Stout D; Pappas K; Arnold LE; Vitiello B; Scahill L; McDougle C; McCracken J; Wheeler C; Martin A; Posey D; Shah B
    Psychopharmacology (Berl); 2007 Mar; 191(1):149-57. PubMed ID: 17123125
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risperidone for the core symptom domains of autism.
    Adetunji B; Mathews M; Osinowo T; Williams A
    Am J Psychiatry; 2006 Mar; 163(3):551; author reply 551-2. PubMed ID: 16513891
    [No Abstract]   [Full Text] [Related]  

  • 48. Risperidone in young children with pervasive developmental disorders and other developmental disabilities.
    Demb HB
    J Child Adolesc Psychopharmacol; 1996; 6(1):79-80. PubMed ID: 9231302
    [No Abstract]   [Full Text] [Related]  

  • 49. [Differences in cerebral blood flow following risperidone treatment in children with autistic disorder].
    Ozdemir DF; Karabacak NI; Akkaş B; Akdemir O; Unal F; Senol S
    Turk Psikiyatri Derg; 2009; 20(4):346-56. PubMed ID: 20013426
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multifocal atrial tachycardia caused by risperidone.
    Oner T; Akdeniz C; Adaletli H
    Int J Cardiol; 2016 Jan; 203():855-7. PubMed ID: 26599751
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risperidone-induced priapism in an autistic child: a case report.
    Aabbassi B; Benali A; Asri F
    J Med Case Rep; 2016 Jun; 10():164. PubMed ID: 27266696
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [An open trial of risperidone in autistic children].
    Nishimura M; Hashimoto T; Miyazaki M; Mori K; Kuroda Y
    No To Hattatsu; 2003 Nov; 35(6):473-7. PubMed ID: 14631742
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Autism spectrum disorders: update of evaluation and treatment.
    Mikhail AG; King BH
    Curr Psychiatry Rep; 2001 Oct; 3(5):361-5. PubMed ID: 11559471
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risperidone in the treatment of pervasive developmental disorder.
    Purdon SE; Lit W; Labelle A; Jones BD
    Can J Psychiatry; 1994 Sep; 39(7):400-5. PubMed ID: 7527293
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment in multisite randomized clinical trials of patients with autistic disorder: the Autism RUPP Network. Research Units on Pediatric Psychopharmacology.
    Arnold LE; Aman MG; Martin A; Collier-Crespin A; Vitiello B; Tierney E; Asarnow R; Bell-Bradshaw F; Freeman BJ; Gates-Ulanet P; Klin A; McCracken JT; McDougle CJ; McGough JJ; Posey DJ; Scahill L; Swiezy NB; Ritz L; Volkmar F
    J Autism Dev Disord; 2000 Apr; 30(2):99-111. PubMed ID: 10832774
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Open-label risperidone treatment of 6 children and adolescents with autism.
    Vercellino F; Zanotto E; Ravera G; Veneselli E
    Can J Psychiatry; 2001 Aug; 46(6):559-60. PubMed ID: 11526814
    [No Abstract]   [Full Text] [Related]  

  • 57. [Autistic disorder: current psychopharmacological treatments and areas of interest for future developments].
    Nikolov R; Jonker J; Scahill L
    Braz J Psychiatry; 2006 May; 28 Suppl 1():S39-46. PubMed ID: 16791391
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessment of the integrity of study blindness in a pediatric clinical trial of risperidone.
    Vitiello B; Davies M; Arnold LE; McDougle CJ; Aman M; McCracken JT; Scahill L; Tierney E; Posey DJ; Swiezy NB; Koenig K
    J Clin Psychopharmacol; 2005 Dec; 25(6):565-9. PubMed ID: 16282839
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of functional analysis methodology in the evaluation of medication effects.
    Crosland KA; Zarcone JR; Lindauer SE; Valdovinos MG; Zarcone TJ; Hellings JA; Schroeder SR
    J Autism Dev Disord; 2003 Jun; 33(3):271-9. PubMed ID: 12908830
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Priapism associated with risperidone in a 21-year-old male with autism.
    Pradhan T; Hardan A
    J Child Adolesc Psychopharmacol; 2013 Jun; 23(5):367-8. PubMed ID: 23738870
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.